Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Best Practice & Research. Clinical Endocrinology & Metabolism|December 13, 2023
The pathophysiology of hypophosphatemiaNobuaki Ito, Naoko Hidaka, Hajime KatoEndocrinology and Metabolism (Seoul, Korea)|March 11, 2024
Acquired Forms of Fibroblast Growth Factor 23-Related Hypophosphatemic OsteomalaciaNobuaki Ito, Naoko Hidaka, Hajime KatoThe Journal of Clinical Endocrinology and Metabolism|September 20, 2022
Machine Learning-Based Prediction of Elevated PTH Levels Among the US General PopulationHajime Kato, Yoshitomo Hoshino, Naoko Hidaka, et al.Bone Reports|January 13, 2022
Radiological evaluation of pseudofracture after the administration of asfotase alfa in an adult with benign prenatal hypophosphatasia: A case reportHajime Kato, Naoko Hidaka, Minae Koga, et al.International Journal of Endocrinology|November 8, 2021
Altered Thyroid Function Tests Observed in Hypophosphatasia Patients Treated with Asfotase AlfaHajime Kato, Naoko Hidaka, Minae Koga, et al.Bone Reports|February 23, 2023
Clinical performance of a new intact FGF23 immunoassay in healthy individuals and patients with chronic hypophosphatemiaHajime Kato, Hiromi Miyazaki, Takehide Kimura, et al.Bone Reports|October 27, 2022
Incidence of ossification of the spinal ligaments in acromegaly patientsYoshitomo Hoshino, Naoko Hidaka, Hajime Kato, et al.Journal of Bone and Mineral Metabolism|August 5, 2021
Performance evaluation of the new chemiluminescent intact FGF23 assay relative to the existing assay systemHajime Kato, Naoko Hidaka, Minae Koga, et al.Bone Reports|December 13, 2021
Induction of FGF23-related hypophosphatemic osteomalacia by alcohol consumptionNaoko Hidaka, Hajime Kato, Minae Koga, et al.JACC. Advances|June 28, 2024
FGF-23, Left Ventricular Hypertrophy, and Mortality in Patients With CKD: A Revisit With Mediation AnalysisNaoko Hidaka, Kosuke Inoue, Hajime Kato, et al.Pageof 3